TSLA
Tesla, Inc.
TSLA's fundamentals are mixed, but it looks expensive: trading at 437x earnings, more than twice its usual 175x. Analysts expect earnings growth, though they disagree widely on how much.
VENU
Venu Holding Corporation
There isn't enough reported data to score VENU yet.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
VENU Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
VENU's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
VENU PE Valuation
VENU has no meaningful PE right now: it lost money over the past year.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
VENU Forward outlook
There aren't enough analyst estimates for VENU to show an outlook.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA has the edge over VENU in the latest year-over-year earnings comparison.
VENU Earnings Per Share
VENU lost $0.91 per share over the past year, a bigger loss than the year before.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA has the edge over VENU on profitability, with a higher operating margin.
VENU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8M | +6.9% |
| Q1 2026 | $3.9M | +11% |
| Q4 2025 | $4.5M | +6.1% |
| Q3 2025 | $5.4M | -1.2% |
| Q2 2025 | $4.5M | +7.5% |
| Q1 2025 | $3.5M | -11% |
| Q4 2024 | $4.3M | +9.1% |
| Q3 2024 | $5.5M | +39% |
VENU has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -320% | -90 points |
| Q1 2026 | -294% | +235 points |
| Q4 2025 | -162% | -12 points |
| Q3 2025 | -185% | -118 points |
| Q2 2025 | -230% | -126 points |
| Q1 2025 | -530% | -201 points |
| Q4 2024 | -150% | -73 points |
| Q3 2024 | -67% | +3 points |
VENU's operating margin was −320% last quarter, down 90 points from the same quarter a year ago.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
VENU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$67.9M | -$50.3M |
| Q1 2026 | -$74.4M | -$43.3M |
| Q4 2025 | -$52.4M | -$31.9M |
| Q2 2025 | -$17.6M | -$4.1M |
| Q1 2025 | -$31.1M | -$19.4M |
| Q4 2024 | -$20.4M | -$10.1M |
VENU has burned cash in almost every quarter: −$228M over the past year, against −$83M the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has the edge over VENU on shareholder dilution, with a more favorable share count trend.
VENU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +12.4M shares |
| 1 year | +59% | +22M shares |
VENU has 59M diluted shares, up 59% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has more cash than debt.
VENU Net Leverage
VENU's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
VENU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.1 | Oversold |
| Stochastic | 15.7 | Oversold |
VENU's weekly RSI is 27 (oversold) and its Stochastic is 16 (oversold).
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
VENU PE vs Consumer Cyclical Sector
VENU has no meaningful PE right now: it lost money over the past year.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has stronger trend alignment. TSLA is above 5 of 5 weekly averages versus VENU above 0 of 4.
VENU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 5.3% below |
| 20 week MA | $1.76 | 29% below |
| 50 week MA | $3.95 | 68% below |
| 100 week MA | $7.49 | 83% below |
VENU is in a downtrend: it's below all four of its weekly moving averages, and 83% below its 100-week average.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over VENU on returns for 2026, with the stronger performance.
VENU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.8 | $9.74 | -9.8% |
| 2025 | $9.74 | $8.17 | -16% |
| 2026 YTD | $8.17 | $1.25 | -85% |
VENU has finished every year since 2024 lower, and it's down 85% so far in 2026.